By interweaving nucleic acid scientists with clinicians dedicated to finding new cures, our goal is to create a new paradigm for organizing molecular research that enables the rapid application of new biological discoveries to solutions for unmet challenges in human health.
Athma A. Pai, PhD, assistant professor of RNA therapeutics, was awarded a nearly $1 million CAREER grant from the National Science Foundation (NSF) to use new high-throughput genomics approaches to study the regulation of mRNA splicing. Read more»
Save the dates for June 21-23, 2023 for the 5th annual RNA Therapeutics Symposium. Inclusivity and family support awards are available!
ScienceLIVE is an educational science outreach program for Worcester area middle schools. We provide opportunities for students to engage with our diverse postdoctoral and graduate student trainees through interactive, exciting virtual and hands-on STEM activities.
Dr. Wen Xue at the RNA Therapeutics Institute at University of Massachusetts Chan Medical School and Dr. Daniel Anderson at MIT have designed a new type of nanoparticle that can be administered to the lungs, where it can deliver messenger RNA (mRNA) encoding useful proteins. mRNA holds great potential as a therapeutic for treating a variety of diseases caused by faulty genes. One obstacle to its deployment thus far has been difficulty in delivering it to the right part of the body, without off-target effects. Read more about Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing at Nature Biotechnology.
Meet Craig Mello, part of the RTI at UMass Chan, who was awarded the 2006 Nobel Prize in Physiology or Medicine, with Andrew Z. Fire, for the discovery of RNA interference. The discovery of RNAi has given scientists unprecedented opportunities to develop new life-saving therapies and advance our basic understanding of biology.
Worcester, known as the “Heart of the Commonwealth” is located in Central Massachusetts
